NASDAQ
InNexus Biotechnology, Inc. (IXSBF) has a free cash flow growth of -77.66% as of Friday, May 29, 2026. This represents a 302.35% decrease compared to its 12-month average of 38.38%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.